PTGX logo

Protagonist Therapeutics (PTGX) Long Term Liabilities

Annual Total Long Term Liabilities

$0.00
-$1.14 M-100.00%

31 December 2023

PTGX Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$27.36 M
-$4.36 M-13.75%

30 September 2024

PTGX Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PTGX Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+100.0%
3 y3 years-100.0%+648.1%
5 y5 years-100.0%-30.8%

PTGX Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-100.0%-13.8%
5 y5 years-100.0%-30.8%
alltimeall time-100.0%-30.8%

Protagonist Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$27.36 M(-13.8%)
June 2024
-
$31.73 M(+9.7%)
Mar 2024
-
$28.92 M(>+9900.0%)
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
Sept 2023
-
$0.00(0.0%)
June 2023
-
$0.00(-100.0%)
Mar 2023
-
$462.00 K(-59.5%)
Dec 2022
$1.14 M(-68.8%)
$1.14 M(-36.8%)
Sept 2022
-
$1.80 M(-26.2%)
June 2022
-
$2.45 M(-20.1%)
Mar 2022
-
$3.06 M(-16.3%)
Dec 2021
$3.66 M(-20.8%)
$3.66 M(-16.1%)
Sept 2021
-
$4.36 M(+14.3%)
June 2021
-
$3.81 M(-9.7%)
Mar 2021
-
$4.22 M(-8.6%)
Dec 2020
$4.62 M
$4.62 M(-49.6%)
Sept 2020
-
$9.17 M(-58.6%)
June 2020
-
$22.14 M(-38.3%)
DateAnnualQuarterly
Mar 2020
-
$35.86 M(-9.3%)
Dec 2019
$39.55 M(+4849.6%)
$39.55 M(+38.8%)
Sept 2019
-
$28.49 M(-6.5%)
June 2019
-
$30.47 M(+340.0%)
Mar 2019
-
$6.92 M(+766.6%)
Dec 2018
$799.00 K(+46.1%)
$799.00 K(+0.3%)
Sept 2018
-
$797.00 K(+0.5%)
June 2018
-
$793.00 K(+14.3%)
Mar 2018
-
$694.00 K(+26.9%)
Dec 2017
$547.00 K(>+9900.0%)
$547.00 K(+64.8%)
Sept 2017
-
$332.00 K(+300.0%)
June 2017
-
$83.00 K(>+9900.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(-100.0%)
$0.00(0.0%)
Sept 2016
-
$0.00(0.0%)
June 2016
-
$0.00(-100.0%)
Mar 2016
-
$1.00 M(-52.7%)
Dec 2015
$2.12 M(+107.5%)
$2.12 M
Dec 2014
$1.02 M
-

FAQ

  • What is Protagonist Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly long term liabilities year-on-year change?

What is Protagonist Therapeutics annual total long term liabilities?

The current annual total long term liabilities of PTGX is $0.00

What is the all time high annual total long term liabilities for Protagonist Therapeutics?

Protagonist Therapeutics all-time high annual total long term liabilities is $39.55 M

What is Protagonist Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of PTGX is $27.36 M

What is the all time high quarterly long term liabilities for Protagonist Therapeutics?

Protagonist Therapeutics all-time high quarterly total long term liabilities is $39.55 M

What is Protagonist Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, PTGX quarterly total long term liabilities has changed by +$27.36 M (+100.00%)